Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$8.59 - $20.77 $917,042 - $2.22 Million
-106,757 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$15.52 - $35.65 $40.3 Million - $92.5 Million
-2,594,156 Reduced 96.05%
106,757 $2.02 Million
Q4 2021

Feb 11, 2022

SELL
$28.89 - $35.33 $1.69 Million - $2.07 Million
-58,486 Reduced 2.12%
2,700,913 $94.8 Million
Q3 2021

Nov 15, 2021

SELL
$35.66 - $42.94 $18.3 Million - $22 Million
-511,901 Reduced 15.65%
2,759,399 $101 Million
Q2 2021

Aug 16, 2021

SELL
$23.7 - $39.27 $6.16 Million - $10.2 Million
-259,851 Reduced 7.36%
3,271,300 $128 Million
Q1 2021

May 17, 2021

BUY
$27.01 - $36.8 $13.3 Million - $18.1 Million
492,196 Added 16.2%
3,531,151 $99.8 Million
Q4 2020

Feb 12, 2021

BUY
$27.51 - $34.36 $4.35 Million - $5.43 Million
158,013 Added 5.48%
3,038,955 $97.3 Million
Q3 2020

Nov 16, 2020

BUY
$25.8 - $34.61 $3.41 Million - $4.57 Million
132,033 Added 4.8%
2,880,942 $93.1 Million
Q2 2020

Aug 14, 2020

BUY
$17.65 - $28.05 $16.1 Million - $25.6 Million
911,480 Added 49.61%
2,748,909 $75.8 Million
Q1 2020

May 14, 2020

BUY
$15.19 - $29.51 $328,179 - $637,563
21,605 Added 1.19%
1,837,429 $32.8 Million
Q4 2019

Feb 11, 2020

BUY
$17.17 - $25.95 $31.2 Million - $47.1 Million
1,815,824 New
1,815,824 $45.5 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.46B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.